1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Anlotinib: new trials by email Literature Review of Anlotinib trials Research Report on Anlotinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer Anlotinib plus AK105 - Anlotinib, Anti-PD-1 Antibody | Phase 1 / Phase 2 | Unknown | Peking Union Medical College Hospital | 29 | 2021-05-12 | 2023-06-22 |
anlotinib (1)
Peking Union Medical College Hospital (1)
China (1)